Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Factors responsible for coverage and compliance in mass drug administration during the programme to eliminate lymphatic filariasis in the East Godavari District, South India.

Identifieur interne : 008E97 ( Main/Exploration ); précédent : 008E96; suivant : 008E98

Factors responsible for coverage and compliance in mass drug administration during the programme to eliminate lymphatic filariasis in the East Godavari District, South India.

Auteurs : B V Babu [Inde] ; K. Satyanarayana

Source :

RBID : pubmed:12680538

Descripteurs français

English descriptors

Abstract

The paper attempts to report the factors responsible for the coverage and compliance of mass diethylcarbamazine citrate (DEC) administration, during the programme to eliminate lymphatic filariasis in the East Godavari District of Andhra Pradesh, India. The evaluation survey indicates that single dose DEC was received by 77% and taken by 64% of eligible people. Reasons for non-reception and non-consumption of the drug at household level were identified. The factors that influenced the coverage and compliance of treatment are broadly categorized as health services related, community related and drug related factors. The study identified some key factors to be followed for the success of the programme.

DOI: 10.1177/004947550303300208
PubMed: 12680538


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Factors responsible for coverage and compliance in mass drug administration during the programme to eliminate lymphatic filariasis in the East Godavari District, South India.</title>
<author>
<name sortKey="Babu, B V" sort="Babu, B V" uniqKey="Babu B" first="B V" last="Babu">B V Babu</name>
<affiliation wicri:level="1">
<nlm:affiliation>Regional Medical Research Centre, Indian Council of Medical Research, SE Rly Project Complex (Post), Bhubaneswar 751 023, India. babubv@satyam.net.in</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Regional Medical Research Centre, Indian Council of Medical Research, SE Rly Project Complex (Post), Bhubaneswar 751 023</wicri:regionArea>
<wicri:noRegion>Bhubaneswar 751 023</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Satyanarayana, K" sort="Satyanarayana, K" uniqKey="Satyanarayana K" first="K" last="Satyanarayana">K. Satyanarayana</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2003">2003</date>
<idno type="RBID">pubmed:12680538</idno>
<idno type="pmid">12680538</idno>
<idno type="doi">10.1177/004947550303300208</idno>
<idno type="wicri:Area/PubMed/Corpus">004298</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004298</idno>
<idno type="wicri:Area/PubMed/Curation">004298</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004298</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004298</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004298</idno>
<idno type="wicri:Area/Ncbi/Merge">000D11</idno>
<idno type="wicri:Area/Ncbi/Curation">000D11</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000D11</idno>
<idno type="wicri:doubleKey">0049-4755:2003:Babu B:factors:responsible:for</idno>
<idno type="wicri:Area/Main/Merge">009191</idno>
<idno type="wicri:Area/Main/Curation">008E97</idno>
<idno type="wicri:Area/Main/Exploration">008E97</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Factors responsible for coverage and compliance in mass drug administration during the programme to eliminate lymphatic filariasis in the East Godavari District, South India.</title>
<author>
<name sortKey="Babu, B V" sort="Babu, B V" uniqKey="Babu B" first="B V" last="Babu">B V Babu</name>
<affiliation wicri:level="1">
<nlm:affiliation>Regional Medical Research Centre, Indian Council of Medical Research, SE Rly Project Complex (Post), Bhubaneswar 751 023, India. babubv@satyam.net.in</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Regional Medical Research Centre, Indian Council of Medical Research, SE Rly Project Complex (Post), Bhubaneswar 751 023</wicri:regionArea>
<wicri:noRegion>Bhubaneswar 751 023</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Satyanarayana, K" sort="Satyanarayana, K" uniqKey="Satyanarayana K" first="K" last="Satyanarayana">K. Satyanarayana</name>
</author>
</analytic>
<series>
<title level="j">Tropical doctor</title>
<idno type="ISSN">0049-4755</idno>
<imprint>
<date when="2003" type="published">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Attitude of Health Personnel</term>
<term>Attitude to Health (ethnology)</term>
<term>Community Health Services (methods)</term>
<term>Diethylcarbamazine (therapeutic use)</term>
<term>Elephantiasis, Filarial (epidemiology)</term>
<term>Elephantiasis, Filarial (prevention & control)</term>
<term>Filaricides (therapeutic use)</term>
<term>Humans</term>
<term>India (epidemiology)</term>
<term>Patient Compliance</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Attitude du personnel soignant</term>
<term>Attitude envers la santé (ethnologie)</term>
<term>Diéthylcarbamazine (usage thérapeutique)</term>
<term>Filaricides (usage thérapeutique)</term>
<term>Filariose lymphatique ()</term>
<term>Filariose lymphatique (épidémiologie)</term>
<term>Humains</term>
<term>Inde (épidémiologie)</term>
<term>Observance thérapeutique</term>
<term>Services de santé communautaires ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Diethylcarbamazine</term>
<term>Filaricides</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>India</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="ethnologie" xml:lang="fr">
<term>Attitude envers la santé</term>
</keywords>
<keywords scheme="MESH" qualifier="ethnology" xml:lang="en">
<term>Attitude to Health</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Community Health Services</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Diéthylcarbamazine</term>
<term>Filaricides</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Filariose lymphatique</term>
<term>Inde</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Attitude of Health Personnel</term>
<term>Humans</term>
<term>Patient Compliance</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Attitude du personnel soignant</term>
<term>Filariose lymphatique</term>
<term>Humains</term>
<term>Observance thérapeutique</term>
<term>Services de santé communautaires</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Inde</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The paper attempts to report the factors responsible for the coverage and compliance of mass diethylcarbamazine citrate (DEC) administration, during the programme to eliminate lymphatic filariasis in the East Godavari District of Andhra Pradesh, India. The evaluation survey indicates that single dose DEC was received by 77% and taken by 64% of eligible people. Reasons for non-reception and non-consumption of the drug at household level were identified. The factors that influenced the coverage and compliance of treatment are broadly categorized as health services related, community related and drug related factors. The study identified some key factors to be followed for the success of the programme.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Inde</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Satyanarayana, K" sort="Satyanarayana, K" uniqKey="Satyanarayana K" first="K" last="Satyanarayana">K. Satyanarayana</name>
</noCountry>
<country name="Inde">
<noRegion>
<name sortKey="Babu, B V" sort="Babu, B V" uniqKey="Babu B" first="B V" last="Babu">B V Babu</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 008E97 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 008E97 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:12680538
   |texte=   Factors responsible for coverage and compliance in mass drug administration during the programme to eliminate lymphatic filariasis in the East Godavari District, South India.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:12680538" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024